Literature DB >> 11733562

Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis.

K Setoguchi1, Y Misaki, Y Terauchi, T Yamauchi, K Kawahata, T Kadowaki, K Yamamoto.   

Abstract

Peroxisome proliferator-activated receptor-gamma (PPAR gamma) controls adipogenesis and glucose metabolism. It was reported recently that PPAR gamma activation by its agonistic ligands modifies lymphocyte function. Since synthetic ligands are known to exert their effect via PPAR gamma-dependent and -independent pathways, we examined the physiological role of PPAR gamma in lymphocytes by using heterozygote mutant mice in which one allele of PPAR gamma is deleted (PPAR gamma(+/-)). In contrast to T cells, which did not exhibit a significant difference, B cells from PPAR gamma(+/-) showed an enhanced proliferative response to stimulation by either lipopolysaccharide or cross-linking of antigen receptors. Dysregulation of the NF-kappa B pathway in B cells from PPAR gamma(+/-) was indicated by spontaneous NF-kappa B activation, as well as increased I kappa B alpha phosphorylation and gel-shift activity following LPS stimulation. Mice primed with either ovalbumin or methylated BSA also showed enhanced antigen-specific immune response of both T and B cells, an immunological abnormality that exacerbated antigen-induced arthritis. These findings indicate that PPAR gamma plays a critical role in the control of B cell response and imply a role in diseases in which B cell hyperreactivity is involved, such as arthritis and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733562      PMCID: PMC200985          DOI: 10.1172/JCI13202

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  PPAR gamma is required for placental, cardiac, and adipose tissue development.

Authors:  Y Barak; M C Nelson; E S Ong; Y Z Jones; P Ruiz-Lozano; K R Chien; A Koder; R M Evans
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  Altered expression level of a systemic nuclear autoantigen determines the fate of immune response to self.

Authors:  K Kawahata; Y Misaki; Y Komagata; K Setoguchi; S Tsunekawa; Y Yoshikawa; J Miyazaki; K Yamamoto
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

Review 3.  Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology.

Authors:  T Lemberger; B Desvergne; W Wahli
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

Review 4.  Initiation and processing of signals from the B cell antigen receptor.

Authors:  M Reth; J Wienands
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  CD3- and CD28-dependent induction of PDE7 required for T cell activation.

Authors:  L Li; C Yee; J A Beavo
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

6.  TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation.

Authors:  X Hu; M Tang; A B Fisher; N Olashaw; K S Zuckerman
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

7.  The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

Authors:  M Ricote; A C Li; T M Willson; C J Kelly; C K Glass
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

8.  PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.

Authors:  C Jiang; A T Ting; B Seed
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

9.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

Authors:  S A Kliewer; J M Lenhard; T M Willson; I Patel; D C Morris; J M Lehmann
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

10.  Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.

Authors:  R T Nolte; G B Wisely; S Westin; J E Cobb; M H Lambert; R Kurokawa; M G Rosenfeld; T M Willson; C K Glass; M V Milburn
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

View more
  32 in total

1.  PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.

Authors:  Maria Paola Simula; Renato Cannizzaro; Vincenzo Canzonieri; Alessandro Pavan; Stefania Maiero; Giuseppe Toffoli; Valli De Re
Journal:  Mol Med       Date:  2010-03-03       Impact factor: 6.354

2.  Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency.

Authors:  Philippe M Campeau; Olga Astapova; Rebecca Martins; Jean Bergeron; Patrick Couture; Robert A Hegele; Todd Leff; Claude Gagné
Journal:  J Lipid Res       Date:  2012-07-02       Impact factor: 5.922

3.  An essential role of NF-kappaB in the "tumor-like" phenotype of arthritic synoviocytes.

Authors:  Xiangli Li; Sergei S Makarov
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

Review 4.  PPARs and molecular mechanisms of transrepression.

Authors:  Mercedes Ricote; Christopher K Glass
Journal:  Biochim Biophys Acta       Date:  2007-03-12

5.  Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.

Authors:  Chunyan Yang; Seung-Hee Jo; Balazs Csernus; Elizabeth Hyjek; Yifang Liu; Amy Chadburn; Y Lynn Wang
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 6.  The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases.

Authors:  Je-Min Choi; Alfred L M Bothwell
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

Review 7.  Environmental immune disruptors, inflammation and cancer risk.

Authors:  Patricia A Thompson; Mahin Khatami; Carolyn J Baglole; Jun Sun; Shelley A Harris; Eun-Yi Moon; Fahd Al-Mulla; Rabeah Al-Temaimi; Dustin G Brown; Annamaria Colacci; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Amedeo Amedei; Roslida A Hamid; Leroy Lowe; Tiziana Guarnieri; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

8.  Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells.

Authors:  Tatiana M Garcia-Bates; Steven H Bernstein; Richard P Phipps
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

9.  Peroxisome proliferator-activated receptor γ B cell-specific-deficient mice have an impaired antibody response.

Authors:  Sesquile Ramon; Simona Bancos; Thomas H Thatcher; Thomas I Murant; Safiehkhatoon Moshkani; Julie M Sahler; Andrea Bottaro; Patricia J Sime; Richard P Phipps
Journal:  J Immunol       Date:  2012-10-05       Impact factor: 5.422

10.  PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.

Authors:  John S Welch; Mercedes Ricote; Taro E Akiyama; Frank J Gonzalez; Christopher K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.